Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
Sara NaghipourMahsa GhodousiSara RahseparSepideh ElyasiPublished in: Expert review of anti-infective therapy (2020)
HCQ/CQ showed acceptable efficacy in HIV especially as an adjuvant treatment beside routine HAART. However, for some viral infections such as ZIKA, EBOLA, SARS-CoV, and MERS-CoV, human studies are lacking. In the COVID-19 pandemic, in vitro and preliminary human studies showed encouraging findings. However, later well-designed trials and retrospective studies with large sample size not only reported non-significant efficacy but also showed more cardiac adverse reactions. Alkalinization of acid vesicles is the most important mechanism of action.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- endothelial cells
- antiretroviral therapy
- case control
- induced pluripotent stem cells
- coronavirus disease
- hiv infected
- early stage
- hiv positive
- human immunodeficiency virus
- pluripotent stem cells
- zika virus
- left ventricular
- hiv testing
- heart failure
- dengue virus
- men who have sex with men
- adverse drug
- electronic health record